Origo Biosciences: Immunotherapeutics to combat chronic disease

Management

  • Shawn J. Green, PhD, Managing Director

    Dr. Green leverages over a decade of experience as an entrepreneurial scientist and as a senior operating executive of public and private companies, including VP of Research at EntreMed (ENMD) and Co-founder/VP of MaxCyte. He has successfully advanced product candidates from preclinical conceptions to FDA clinical trials. Dr. Green has also authored over 50 publications in such Journals as Science and Nature Medicine. He has also received numerous awards and patents for his work in cancer biology and infectious disease. Dr. Green holds an MBA and PhD from Georgetown University. more... (LinkedIn Profile)

  • John Holaday, PhD, Director

    CEO QRX Pharmaceutical and past executive at EntreMed, Medicus

    pubScholar Profile

  • Chris Yoo, PhD, Advisor

    CEO MedTrust and Sr. Manager with TransMed, Applied Biosystems, LabBook, IBM Life Science

    pubScholar Profile

Origo Biosciences, Inc.   Davis, California
© 2008 Origo Biosciences™ All rights reserved.

website design by Brook Group